Editorial: Parental allies

Article

Pediatricians are advised to do what they can to keep parents informed about children's issues as election day approaches.

Recent Videos
Decreasing antibiotics for acute otitis media and community acquired pneumonia, with Elysha Pifko, MD
Sensory play for children with autism, with Joshua Feder, MD
Stephanie Chao, MD
Feasibility of ambulatory blood pressure monitoring in primary care | Carissa Baker-Smith, MD, MPH
Tina Tan, MD
Camille Walker CPNP-PC, MSN, CPNP Sacheen D. Harris MSN, CPNP-PC
Danielle Van Damme, DNP, CPNP-AC
Karen Y. Capusan, DNP, CPNP-PC
Discussion: AAP's opioid for acute pain clinical practice guideline with Jessica Spruit, DNP
Bobbie Monaco, MSN, CPNP-PC
Related Content
Lea Widdice, MD, director, Adolescent Medicine Fellowship; associate professor, University of Cincinnati Department of Pediatrics, Cincinnati, Ohio.

Uncovering the pediatrician's role in OTC STI testing, with Lea Widdice, MD

Lea Widdice, MD
April 30th 2025
Article

Lea Widdice, MD, details her recent presentation at PAS 2025 on OTC STI testing within pediatrics.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
FDA approves nipocalimab-aahu to treat generalized myasthenia gravis | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves nipocalimab-aahu to treat generalized myasthenia gravis

Joshua Fitch, Senior Editor
April 30th 2025
Article

The human FcRn-blocking monoclonal antibody is indicated for gMG patients aged 12 years and older.

Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
Maternal anemia in pregnancy linked to higher risk of congenital heart disease in offspring | Image Credit: © BazziBa - stock.adobe.com.

Maternal anemia in early pregnancy linked to higher risk of congenital heart disease in offspring

Morgan Ebert, Managing Editor
April 29th 2025
Article

A UK study links maternal anemia in early pregnancy with increased congenital heart disease risk in offspring.

FDA approves pz-cel for recessive dystrophic epidermolysis bullosa | Image Credit: © Calin - © Calin - stock.adobe.com.

FDA approves pz-cel for recessive dystrophic epidermolysis bullosa

Joshua Fitch, Senior Editor
Published: April 29th 2025 | Updated: April 29th 2025
Article

The decision makes pz-cel the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with RDEB.

© 2025 MJH Life Sciences

All rights reserved.